
Please try another search
Small-cap stocks are companies with a market capitalization between $300 million and $2 billion. Historically, such stocks have performed better than large-cap stocks, especially during financial...
Nektar Therapeutics (NASDAQ:NKTR) is a $2B clinical trials biotech company, headquartered in San Francisco, CA. The stock has mostly been hovering around the $20 mark for most of Nektar’s 30+...
For Immediate ReleaseChicago, IL – February 25, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest...
The biotech sector continues to be in focus with regulatory and pipeline updates from quite a few companies. New drug approvals are also in the spotlight. The sector has also been in focus, thanks to...
The stock market finished August with its fifth monthly gain as one of the strongest rallies since 2000 continued pushing higher. Indeed, this rally looks like it has enough momentum to last a while....
Nektar Therapeutics (NASDAQ:NKTR) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to loss of $0.63 per share a year ago. These...
Nektar Therapeutics (NASDAQ:NKTR) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.81. This compares to loss of $0.68 per share a year ago. These...
Nektar Therapeutics (NASDAQ:NKTR) reported a loss of 64 cents per share for the fourth quarter of 2019, narrower than the Zacks Consensus Estimate of a loss of 69 cents but wider than a loss of 57...
AstraZeneca plc (NYSE:AZN) is scheduled to report fourth-quarter and full-year 2019 results on Feb 14The company’s earnings beat estimates in each of the past four quarters with the average...
Alkermes Plc. (NASDAQ:ALKS) is scheduled to release fourth-quarter 2019 results on Feb 13.The company’s surprise history has been impressive so far, having delivered an earnings beat of...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review